infecti
diseas
second
lead
caus
death
worldwid
although
host
multitrop
pathogen
render
manipul
possibl
anim
model
humanrestrict
tropism
numer
virus
bacteria
fungi
parasit
serious
hamper
understand
pathogen
henc
uncov
genet
basi
underli
narrow
tropism
pathogen
critic
understand
mechan
infect
pathogenesi
moreov
genet
dissect
essenti
gener
permiss
anim
model
serv
critic
tool
develop
therapeut
vaccin
challeng
human
pathogen
review
describ
differ
experiment
approach
util
uncov
genet
foundat
regul
pathogen
host
tropism
well
relev
studi
tropism
sever
import
human
pathogen
final
discuss
current
futur
use
knowledg
gener
genet
modifi
anim
model
permiss
pathogen
pathogen
host
tropism
viru
bacteria
genet
engin
human
mice
anim
model
disclosur
statement
dr
ploss
coinventor
patent
cover
use
human
occludin
gener
anim
model
hcv
author
awar
affili
membership
fund
financi
hold
might
perceiv
affect
object
review
recent
updat
global
burden
diseas
estim
approxim
death
femal
male
attribut
infecti
diseas
make
second
lead
caus
death
worldwid
next
cardiovascular
diseas
pathogen
respons
diseas
divers
group
virus
bacteria
parasit
mani
broadli
affect
human
popul
stagger
number
individualsapproxim
millionar
chronic
infect
hepat
b
hbv
c
hcv
virus
leav
increas
risk
develop
sever
liver
diseas
despit
health
educ
effort
still
million
individu
live
hiv
lead
million
aidsrel
death
everi
year
approxim
million
peopl
contract
dengu
viru
denv
annual
almost
million
present
clinic
symptom
forti
percent
world
popul
infect
human
cytomegaloviru
hcmv
lethal
newborn
immunocompromis
individu
parasit
infect
also
significantli
contribut
global
burden
diseas
alon
approxim
million
peopl
diagnos
malaria
caus
plasmodium
parasit
result
half
million
death
addit
bacteri
pathogen
continu
remain
import
health
issu
worldwid
tuberculosi
tb
caus
bacterium
mycobacterium
tuberculosi
kill
million
million
individu
infect
vibrio
cholera
caus
agent
cholera
respons
death
per
year
importantli
continu
emerg
multidrugresist
mdr
bacteria
doubl
patient
death
rate
compar
patient
infect
nonresist
bacteria
mani
pathogen
respons
diseas
infect
highli
restrict
speci
tropism
infect
human
close
relat
nonhuman
primat
nhp
figur
restrict
tropism
creat
signific
difficulti
understand
biolog
pathogen
vivo
serious
hamper
develop
effect
therapeut
overcom
difficulti
develop
small
anim
model
recapitul
life
cycl
pathogen
critic
need
howev
gener
vivo
platform
requir
identif
molecular
determin
govern
speciesspecif
tropism
humantrop
pathogen
host
tropism
pathogen
dictat
varieti
way
given
organ
may
possess
appropri
molecular
factor
may
incompat
ortholog
factor
need
success
infect
receptor
specif
viru
enter
host
cell
bacterium
properli
adher
invad
addit
presenc
host
restrict
factor
block
step
pathogen
life
cycl
replic
within
host
cell
final
vari
abil
pathogen
evad
andor
disrupt
immun
respons
given
host
also
contribut
speci
tropism
although
understand
limit
host
rang
mani
humantrop
pathogen
remain
daunt
task
grow
number
techniqu
avail
tackl
signific
highli
relev
problem
review
cover
varieti
method
implement
vitro
vivo
teas
apart
variou
molecular
need
humantrop
pathogen
barrier
exist
nonpermiss
speci
although
imposs
follow
discuss
fulli
comprehens
aim
focu
particularli
tell
exampl
primarili
studi
viral
bacteri
pathogen
engin
gener
hostadapt
pathogen
direct
engin
assist
evolut
genomewid
genet
screen
vitro
vivo
figur
use
interspeci
heterokaryon
genomewid
lossoffunct
genet
screen
import
number
experiment
approach
employ
uncov
major
host
regul
pathogen
infect
section
present
overview
method
emphasi
use
genet
dissect
host
tropism
humantrop
pathogen
interspeci
heterokaryonsth
exist
speciesspecif
factor
genet
determin
promot
restrict
pathogen
infect
wellestablish
fact
interspeci
heterokaryon
ih
larg
cell
gener
experiment
induct
fusion
cell
type
belong
differ
speci
intens
use
almost
two
decad
determin
whether
posit
neg
regul
pathogen
life
cycl
within
given
speci
figur
briefli
aspect
pathogen
life
cycl
replic
assess
ih
form
permiss
nonpermiss
cell
pathogen
replic
ih
suggest
nonpermiss
cell
line
lack
specif
factor
incompat
ortholog
contrast
absenc
replic
indic
potenti
restrict
factor
present
within
cell
line
earli
observ
infect
vari
across
anim
speci
even
among
close
relat
primat
speci
hint
restrict
factor
present
speci
might
regul
host
tropism
among
possibl
approach
ih
heavili
util
strengthen
evid
exist
factor
primat
ultim
enabl
identif
exampl
inabl
infect
macaqu
attribut
part
specif
ortholog
protein
target
capsid
howev
human
ortholog
primat
ortholog
restrict
factor
specif
antagon
viral
accessori
protein
vif
vpu
similarli
hcv
also
narrow
host
tropism
restrict
human
chimpanze
mous
cell
line
refractori
hcv
infect
due
restrict
level
viral
entri
replic
heterokaryon
human
mous
liver
cell
line
gener
identifi
whether
domin
neg
restrict
factor
mous
cell
interf
hcv
life
cycl
howev
complet
hcv
life
cycl
within
ih
demonstr
narrow
tropism
hcv
like
due
absenc
necessari
humanspecif
factor
mous
liver
cell
influenza
virus
also
examin
hostrestrict
tropism
genet
plastic
influenza
virus
tightli
link
abil
replic
within
broad
panel
anim
speci
howev
determin
regul
suscept
given
host
influenza
virus
well
understood
exampl
polymeras
avian
influenza
viru
poor
effici
human
cell
thu
restrict
viral
replic
yet
ih
human
avian
cell
still
support
viral
replic
ultim
demonstr
human
lack
posit
regul
replic
need
effect
viral
polymeras
activ
cdna
complement
screen
compar
transcriptomicsalthough
use
ih
valuabl
predict
presenc
posit
neg
regul
pathogen
infect
addit
approach
need
precis
identifi
natur
regul
figur
complementari
dna
cdna
librari
screen
compar
transcriptom
cdna
subtract
gene
array
permiss
nonpermiss
cell
valuabl
tool
identifi
critic
hostspecif
determin
pathogen
infect
first
approach
identifi
restrict
factor
involv
preintegr
stage
viral
replic
express
permiss
cell
cdna
librari
deriv
primari
rhesu
macaqu
lung
fibroblast
identifi
one
factor
macaqu
ortholog
shown
target
capsid
inhibit
earli
step
infect
thu
highlight
protein
strong
determin
host
tropism
similarli
follow
identif
hcv
entri
factor
scaveng
receptor
class
b
type
srbi
murin
cell
line
express
molecul
nonetheless
nonpermiss
hcv
entri
highlight
need
addit
entri
factor
cdna
screen
use
librari
deriv
permiss
human
hepatoma
cell
line
appli
mous
cell
line
overexpress
human
ortholog
srbi
screen
identifi
occludin
ocln
addit
necessari
factor
express
along
srbi
mous
nonpermiss
human
cell
line
enabl
hcv
entri
importantli
screen
demonstr
hcv
entri
requir
human
ortholog
ocln
although
srbi
could
human
mous
origin
find
combin
identif
human
factor
necessari
hcv
replic
viral
particl
product
permit
develop
engin
murin
cell
line
allow
complet
entir
hcv
life
cycl
vitro
compar
transcriptom
identifi
key
regul
host
tropism
uncov
restrict
factor
postintegr
stage
infect
cdna
subtract
screen
use
cell
line
suscept
nonsuscept
infect
lack
accessori
protein
vif
identifi
restrict
factor
counteract
vif
primari
cell
target
human
cell
importantli
vif
unabl
counteract
primat
ortholog
restrict
factor
also
known
tetherin
inhibit
particl
releas
also
identifi
compar
transcriptom
use
microarray
approach
cell
treat
absenc
protein
vpu
induc
accumul
particl
cell
surfac
microarray
analys
cell
line
treat
untreat
reveal
vpu
counteract
inhibitori
action
human
tetherin
howev
primat
tetherin
unaffect
vpu
inde
simian
counterpart
simian
immunodefici
viru
siv
use
differ
accessori
protein
nef
counteract
primat
tetherin
ortholog
wholegenom
genet
screensmani
discoveri
made
via
cdna
complement
assay
compar
transcriptom
guid
earlier
experiment
observ
hypothes
howev
even
absenc
preliminari
experiment
evid
determin
host
tropism
still
uncov
via
rout
purpos
wholegenom
genet
lossoffunct
screen
particular
interest
figur
although
small
interf
rna
sirna
small
hairpin
rna
shrna
screen
proven
use
identifi
host
factor
import
pathogen
propag
vari
knockdown
effici
offtarget
effect
techniqu
pose
challeng
recent
haploid
screen
small
noncod
rnabas
screen
found
traction
address
shortcom
diploid
genom
mammal
import
limit
largescal
genet
screen
aim
robustli
disrupt
gene
express
identifi
gene
involv
key
biolog
process
haploid
screen
recent
emerg
innov
strategi
overcom
limit
use
human
chronic
myeloid
leukemia
cell
line
harbor
haploid
karyotyp
except
chromosom
largescal
genet
screen
establish
identifi
host
gene
involv
suscept
pathogen
disrupt
gene
express
retrovirusmedi
gene
inactiv
strategi
employ
wherebi
tag
insert
gene
thu
permit
identif
deplet
gene
importantli
screen
identifi
host
factor
import
influenza
infect
well
involv
cytotox
effect
bacteri
toxin
haploid
screen
also
contribut
understand
host
factor
regul
viral
entri
genomewid
haploid
genet
screen
cholesterol
transport
niemannpick
identifi
critic
host
factor
ebola
viru
ebov
entri
host
cell
anoth
hemorrhag
fever
viru
lassa
viru
infect
target
cell
bind
glycosyl
recent
haploid
screen
identifi
sever
host
factor
involv
glycosyl
interestingli
despit
viru
engag
avian
cell
remain
resist
lassa
viru
infect
human
rodent
cell
permiss
viru
propag
second
haploid
screen
found
sialyltransferas
critic
interact
lassa
surfac
glycoprotein
host
lysosomeresid
protein
viral
entri
interact
depend
singl
amino
acid
residu
present
rodent
absent
avian
ortholog
thu
possibl
explain
resist
avian
cell
infect
despit
util
worth
note
genet
instabl
haploid
cell
may
hamper
identif
import
host
factor
haploid
cell
screen
long
limit
small
number
avail
cell
type
suitabl
studi
infect
particular
humantrop
pathogen
howev
number
experiment
system
resolut
haploid
screen
strategi
recent
improv
addit
recent
gener
haploid
embryon
stem
es
cell
mice
macaqu
could
permit
addit
genet
screen
deciph
determin
mammalian
suscept
pathogen
although
remain
shown
es
cell
util
would
need
differenti
matur
tissu
type
even
though
mani
type
continu
prolifer
thu
amen
highthroughput
screen
target
host
transcriptom
repres
valuabl
strategi
uncov
host
factor
regul
life
cycl
challeng
pathogen
particular
studi
use
sirna
shrna
librari
identifi
regul
viral
infect
three
studi
use
sirna
cell
line
unveil
number
host
depend
critic
particular
step
life
cycl
viral
entri
transcript
although
compar
analysi
demonstr
lack
overlap
hit
three
screen
respect
find
consist
term
gene
ontolog
sirnabas
screen
also
appli
search
factor
regul
member
famili
flavivirida
west
nile
viru
wnv
denv
hcv
although
sever
sirna
screen
focus
particular
host
target
involv
hcv
life
cycl
two
major
wholegenom
sirna
screen
date
perform
uncov
hcv
host
depend
one
studi
focus
host
factor
regul
viral
rna
replic
use
cell
line
express
select
viral
rnaa
socal
hcv
replicon
therebi
author
abl
identifi
factor
regul
hcv
replic
contrast
second
studi
employ
infecti
hcv
clone
abl
replic
cell
cultur
perform
wholegenom
sirna
screen
thu
allow
identif
number
import
host
factor
regul
differ
stage
hcv
life
cycl
impact
factor
defin
step
viral
life
cycl
recent
interrog
challeng
vitro
regard
member
flavivirida
famili
similar
sirna
screen
also
unveil
import
host
regul
wnv
denv
infect
factor
involv
endocytosi
intracellular
traffick
well
antivir
respons
mammalian
cell
drosophila
recent
origin
vivo
sirna
screen
approach
deliv
sirna
librari
mice
use
replicationcompet
sindbi
viru
rna
viru
famili
togavirida
result
natur
select
viral
variant
carri
sirna
advantag
viral
replic
surviv
thu
uncov
direct
effector
neg
host
regul
antivir
respons
futur
genomescal
knockout
screen
see
engin
genom
vivo
uniqu
robust
compar
small
rnabas
screen
may
employ
uncov
new
host
regul
pathogen
infect
although
host
speci
harbor
import
set
factor
posit
neg
regul
pathogen
tropism
pathogen
also
carri
genet
detemin
strongli
regul
tropism
variou
experiment
approach
employ
past
decad
identifi
pathogen
regul
host
tropism
describ
method
identifi
import
pathogenmedi
mechan
regul
host
tropism
pathogen
adaptationth
adapt
pathogen
vitro
vivo
new
host
speci
remain
relev
strategi
identifi
pathogen
determin
regul
host
tropism
figur
hcv
molecular
clone
serial
passag
human
cell
line
limit
express
endogen
ectop
express
mous
three
mutat
identifi
hcv
envelop
glycoprotein
allow
hcv
overcom
inabl
use
mous
anoth
studi
serum
hcvinfect
patient
passag
chimpanze
select
viral
variant
low
replic
rate
high
viru
product
increas
fit
viral
persist
rhesu
macaqu
resist
infect
due
restrict
factor
target
capsid
protein
follow
viru
entri
although
counteract
human
version
select
capsid
mutat
assist
evolut
permit
restrict
overcom
subsequ
allow
replic
primari
rhesu
macaqu
lymphocyt
similar
vivo
passag
pigtail
macaqu
result
anoth
modifi
viru
antagon
macaqu
restrict
factor
induc
tcell
deplet
caus
aidslik
diseas
recent
gainoffunct
experi
also
demonstr
serial
passag
ferret
emerg
select
avian
influenza
variant
spread
mammal
via
airborn
transmiss
sever
studi
focus
adapt
avian
influenza
virus
replic
human
cell
mutat
identifi
subunit
polymeras
complex
nucleoprotein
novel
polymeras
cofactor
nuclear
export
protein
use
mosquito
inject
serum
patient
infect
chikungunya
viru
chikv
adapt
mutat
within
chikv
envelop
glycoprotein
emerg
vivo
mutat
increas
fit
chikv
replic
mammal
addit
mosquito
speci
although
ebov
lethal
experiment
infect
immunocompet
mice
ebov
zair
strain
serial
passag
mice
prove
lethal
follow
intraperiton
inocul
denv
infect
induc
broad
rang
clinic
manifest
human
mild
dengu
fever
dengu
hemorrhag
fever
dengu
shock
syndrom
last
two
sometim
fatal
develop
suitabl
anim
model
hinder
denv
infect
wildtyp
mice
result
low
level
replic
littl
viremia
although
yet
possibl
engin
immunocompet
mice
suscept
infect
denv
mouseadapt
strain
denv
gener
robustli
infect
mice
defici
ifn
receptor
ifn
receptor
nonadapt
denv
serial
passag
mosquito
mice
induc
earli
death
increas
vascular
permeabl
mice
although
clinic
manifest
observ
mice
infect
origin
denv
strain
author
studi
report
mutat
within
e
envelop
glycoprotein
like
mediat
phenotyp
addit
critic
amino
acid
mutat
within
mous
nonadapt
denv
strain
also
report
import
determin
sever
humanlik
denv
pathogenesi
mice
although
mice
commonli
use
vivo
model
denv
infect
restrict
genet
divers
viral
isol
capabl
replic
vivo
highli
immunocompromis
statu
mice
limit
util
recent
work
suggest
denv
infect
mice
antagon
type
ifn
signal
specif
myeloid
cell
popul
mice
harbor
target
disrupt
ifn
receptor
exclus
dendrit
cell
macrophag
suscept
mouseadapt
denv
facilit
infect
optim
broader
rang
mous
nonadapt
viral
strain
addit
refin
model
need
despit
feasibl
pathogen
adapt
approach
note
adapt
mutat
broaden
pathogen
host
rang
may
also
alter
biolog
properti
eg
alter
host
factor
usag
potenti
hamper
util
speciesadapt
pathogen
aim
conduct
relev
character
hostpathogen
interact
vivo
genet
engin
pathogensgenet
engin
conveni
strategi
challeng
host
barrier
pathogen
infect
develop
new
infect
system
creat
amen
costeffect
anim
model
figur
discuss
replic
macaqu
restrict
inabl
hiv
counteract
macaqu
ortholog
sever
restrict
factor
although
siv
gener
induc
aidslik
diseas
primat
speci
macaqueadapt
siv
sivmac
strain
caus
diseas
macaqu
baboon
thu
chimer
sivmacbas
virus
encod
singl
sever
protein
term
shiv
great
interest
past
two
decad
studi
pathogenesi
immun
respons
vivo
among
shiv
model
gener
sivmac
strain
carri
envelop
glycoprotein
emerg
one
power
model
host
antivir
respons
recent
vivo
screen
use
mixtur
unadapt
shiv
harbor
envelop
glycoprotein
patient
identifi
variant
abl
caus
aidslik
diseas
rhesu
macaqu
shiv
essenti
compos
sivmac
genom
viru
encod
genom
sivmac
vif
protein
also
gener
call
simian
tropichuman
immunodefici
viru
sthiv
express
sivmac
vif
counteract
restrict
factor
pigtail
macaqu
persist
infect
detect
sever
month
postinocul
howev
longterm
deplet
aidslik
diseas
could
observ
highlight
need
counteract
restrict
factor
beyond
singl
amino
acid
mutat
ebov
envelop
protein
modul
ebov
host
rang
tropism
character
interestingli
mutat
abrog
bind
human
murin
discuss
host
tropism
given
pathogen
agent
determin
wide
varieti
factor
includ
immun
respons
induc
infect
thu
understand
human
immun
respons
pathogen
agent
appear
necessari
fulli
comprehend
host
tropism
identifi
point
clinic
intervent
creat
relev
vivo
model
howev
understand
remain
highli
challeng
magnitud
kinet
host
innat
immun
respons
given
pathogen
usual
complex
highli
specif
hostpathogen
combin
numer
virus
equip
strategi
specif
evad
host
innat
immun
respons
thu
contribut
host
tropism
case
research
alter
nativ
tropism
viru
manipul
interact
host
immun
respons
exemplifi
work
nonhuman
pathogen
poxviru
myxoma
viru
myxv
myxv
natur
infect
rabbit
wildtyp
mice
resist
infect
due
strong
innat
immun
respons
driven
type
ifn
howev
myxv
abl
infect
mice
disrupt
type
ifn
signal
gener
disrupt
ifn
signal
within
mice
type
ifn
receptorknockout
mice
shown
render
anim
suscept
infect
varieti
differ
virus
far
lower
median
lethal
dose
virus
includ
vesicular
stomat
viru
vsv
well
vaccinia
semliki
forest
lymphocyt
choriomening
virus
vivo
model
especi
relev
humantrop
pathogen
mani
infect
human
case
limit
number
nhp
speci
hepatotrop
viru
hcv
promin
exampl
chimpanze
human
readili
suscept
host
discuss
hcv
life
cycl
complet
mice
express
viral
entri
factor
human
ocln
also
blunt
innat
immun
respons
establish
infect
hcvencod
proteas
cleav
host
cell
mitochondri
antivir
signal
mav
protein
tollinterleukin
receptordomaincontain
adaptorinduc
trif
mav
trif
adaptor
protein
retino
acidinduc
gene
rigi
tolllik
receptor
respect
cleavag
trif
mav
thu
effect
interrupt
downstream
signal
rigi
pathway
highli
import
trigger
host
innat
immun
respons
differ
cleavag
site
mav
prevent
protein
cleavag
differ
nhp
may
explain
least
part
inabl
speci
readili
infect
hcv
mav
abil
propag
immun
respons
also
antagon
influenza
polymeras
complex
sequenc
differ
even
one
residu
influenc
tropism
human
avian
influenza
virus
allud
final
denv
natur
unabl
replic
mice
howev
disrupt
ifn
signal
permit
replic
viral
nonstructur
protein
bind
human
result
degrad
thu
permit
viru
subvert
signal
howev
denv
bind
murin
allow
host
immun
respons
inhibit
viral
replic
host
factor
demonstr
evolut
time
respons
viral
antagon
although
given
mutat
may
select
respons
ancient
viru
adapt
contribut
speci
tropism
modernday
virus
exampl
viral
doublestrand
rna
detect
protein
kinas
r
pkr
mammalian
cell
pkr
phosphoryl
eukaryot
translat
initi
factor
shut
protein
synthesi
vaccinia
viru
encod
mimic
differenti
evolut
pkr
like
respons
ancient
virus
result
vari
resist
suscept
primat
speci
mimicri
similarli
hiv
infect
human
nhp
discuss
section
approach
dissect
limit
host
rang
pathogen
tropism
partial
attribut
speciesspecif
differ
restrict
factor
ortholog
like
evolv
respons
ancient
retrovirus
result
ortholog
protein
old
world
monkey
owl
monkey
success
target
capsid
new
world
monkey
human
evas
host
immun
respons
also
occur
follow
bacteri
infect
bacterium
respons
gonorrhea
occur
human
neisseria
gonorrhoea
util
outer
membran
porin
molecul
bind
host
protein
inhibitor
complement
system
complement
system
part
immun
system
facilit
clearanc
pathogen
complement
action
antibodi
although
serv
host
prevent
destruct
consequ
complement
dysregul
porin
molecul
express
n
gonorrhoea
specif
bind
human
chimpanze
bacterium
effect
elimin
serum
rodent
rabbit
presum
porin
molecul
unabl
bind
speci
similarli
cholinebind
protein
cbpa
also
call
pspc
streptococcu
pneumonia
specif
bind
human
addit
human
factor
polymer
immunoglobulin
receptor
pigr
factor
h
fh
complement
protein
secretori
iga
siga
contribut
immun
evas
pathogen
human
streptococcu
pyogen
interact
surfaceexpos
protein
human
contribut
bacterium
host
specif
allow
bind
human
keratinocyt
subsequ
invad
epitheli
cell
human
pathogen
pneumonia
haemophilu
influenza
n
gonorrhoea
neisseria
meningitidi
activ
disrupt
host
immun
respons
cleav
major
mucos
antibodi
human
test
whether
express
humanspecif
candid
gene
andor
disrupt
put
interf
pathway
render
previous
nonpermiss
speci
suscept
humanspecif
pathogen
numer
genet
manipul
often
necessari
figur
method
suitabl
engin
multicellular
organ
great
precis
refin
past
three
decad
sever
classic
techniqu
knockout
knockin
transgen
organ
use
investig
specif
role
particular
gene
diseas
knockout
achiev
delet
first
sever
code
exon
gene
via
homolog
recombin
result
either
truncat
protein
protein
howev
gene
essenti
organ
develop
viabil
fertil
result
condit
knockout
made
recombinas
technolog
use
enzym
cre
dre
flp
knock
gene
specif
tissu
specif
time
strategi
allow
lethal
circumv
permit
studi
null
phenotyp
convers
gene
also
knock
integr
exogen
gene
specif
noncrit
site
via
homolog
recombin
method
ensur
observ
phenotyp
attribut
high
confid
exogen
gene
express
final
transgen
anim
express
foreign
gene
gene
creat
transfect
es
cell
desir
gene
implant
embryo
femal
mice
b
inject
dna
interest
pronucleu
fertil
embryo
classic
techniqu
timeconsum
laborintens
extrem
low
frequenc
recombin
rang
higherord
eukaryot
major
breakthrough
came
discoveri
effici
gene
target
homolog
recombin
could
enhanc
least
two
three
order
magnitud
follow
introduct
doublestrand
break
dsb
dna
use
rarecut
endonucleas
sever
genomeedit
tool
sinc
develop
facilit
increas
dna
dsb
zinc
finger
nucleas
zfn
transcript
activatorlik
effector
nucleas
talen
cluster
regularli
interspac
short
palindrom
repeat
techniqu
use
disrupt
gene
lead
knockout
insert
correct
even
chromosom
rearrang
although
genom
engin
tool
facilit
dsb
distinct
mechan
see
sidebar
zfn
talen
system
current
limit
zfn
talen
system
zfn
talen
system
use
creat
gene
knockout
knockin
sever
mammalian
organ
includ
mice
rat
pig
monkey
techniqu
especi
facilit
tractabl
genom
engin
last
three
speci
minim
amen
genet
manipul
success
rate
gene
knockout
knockin
vari
wide
littl
depend
system
organ
use
system
use
gener
mice
five
disrupt
gene
one
step
knock
multipl
gene
onestep
process
possibl
studi
interact
multipl
gene
simultan
use
talen
gene
target
mutat
creat
mous
model
earlyonset
epilepsi
lentivir
knockout
librari
mice
creat
along
crecontrol
transgen
mous
facilit
knockout
condit
knockout
screen
mice
librari
contain
code
noncod
region
allow
studi
gene
regulatori
region
pig
zfn
talen
use
creat
biallel
mutat
lowdens
lipoprotein
receptor
respect
talen
also
use
knockout
rat
immunoglobulin
locu
recent
two
gene
recombinas
activ
gene
ablat
cynomolgu
monkey
one
step
inject
specif
grna
mrna
onecellstag
embryo
technolog
provid
tantal
possibl
creat
knockout
nhp
facilit
indepth
studi
gene
function
organ
close
relat
human
addit
gene
correct
made
use
zfn
target
xlink
sever
combin
immunodefici
mutat
interleukin
receptor
common
chain
gene
human
cell
past
year
sever
achiev
made
gener
genet
engin
mous
model
express
specif
human
factor
increas
suscept
mice
humantrop
virus
bacteria
model
led
major
advanc
understand
pathogenesi
vivo
addit
pave
way
new
vaccin
treatment
strategi
figur
review
work
viral
bacteri
pathogen
benefit
develop
genet
human
mice
suggest
futur
direct
studi
addit
challeng
pathogen
applic
studi
viral
pathogenson
first
viral
pathogen
benefit
gener
human
transgen
mice
polioviru
human
polioviru
receptor
pvr
broadli
express
vivo
mice
permit
viral
replic
multipl
polioviru
serotyp
within
central
nervou
system
develop
paralyt
poliomyel
clinic
symptom
similar
human
within
mice
confirm
import
pvr
host
determin
polioviru
pathogenesi
addit
work
highlight
transgen
mice
uniqu
way
studi
polioviru
neurovirul
immunogen
design
novel
vaccin
strategi
inde
collabor
studi
approv
use
mous
model
altern
monkey
test
neurovirul
oral
polioviru
vaccin
opv
howev
mice
suscept
infect
follow
intraspin
oral
inocul
pvrtransgen
mice
defici
receptor
gener
mice
suscept
polioviru
infect
follow
oral
inocul
demonstr
role
innat
immun
respons
regul
polioviru
pathogenesi
alimentari
tract
howev
effici
immun
respons
observ
model
follow
opv
inocul
high
origin
pvrtransgen
mice
transgen
mous
model
also
develop
studi
measl
viru
mv
sever
group
develop
humantransgen
mice
express
human
mv
receptor
ubiquit
express
receptor
mice
render
tissu
lung
kidney
permiss
vivo
mv
also
activ
b
cell
yet
cell
type
macrophag
remain
nonpermiss
mv
infect
indic
presenc
murinespecif
factor
capabl
restrict
viral
infect
transgen
express
human
central
nervou
system
mice
made
suscept
mv
infect
neurolog
diseas
howev
none
studi
abl
recapitul
human
clinic
featur
diseas
mice
remain
incomplet
permiss
mv
infect
human
deriv
yeast
artifici
chromosom
librari
express
mice
importantli
locat
level
human
express
mice
closest
found
human
ever
report
mv
abl
replic
central
nervou
system
immun
system
could
also
spread
neuron
caus
death
anim
day
postinfect
discuss
hcv
display
narrow
host
tropism
restrict
studi
vivo
differ
approach
taken
gener
tractabl
small
anim
model
strategi
broadli
divid
viral
host
adapt
approach
one
host
adapt
strategi
render
nonpermiss
speci
suscept
hcv
relev
tissu
xenotransplant
human
liver
cell
suitabl
xenorecipi
mice
second
host
adapt
strategi
reli
develop
genet
engin
mous
model
express
human
factor
permit
hcv
replic
within
partial
fulli
function
immun
system
context
find
viral
entri
via
human
host
factor
ocln
regul
hcv
host
tropism
viral
assembl
replic
pave
way
gener
genet
human
mous
model
permiss
hcv
infect
inde
adenovirusmedi
express
hcv
entri
factor
ocln
hepatocyt
immunocompet
mice
allow
hcv
uptak
murin
hepatocyt
vivo
howev
model
viral
replic
detect
de
novo
viral
particl
product
observ
like
murin
innat
adapt
immun
pressur
two
year
later
transgen
express
four
canon
hcv
entri
factor
srbi
ocln
within
mice
harbor
target
disrupt
gene
involv
antivir
innat
defens
receptor
final
allow
lowlevel
replic
de
novo
infecti
particl
product
mice
band
tcell
respons
could
also
observ
howev
magnitud
qualiti
respons
like
impair
murin
defici
sinc
similar
model
base
transgen
express
ocln
fulli
immunocompet
icr
imprint
control
region
mice
report
sustain
viremia
observ
mice
well
hepatopatholog
manifest
infect
highlight
potenti
impact
murin
genet
background
pathogen
permiss
howev
viral
load
serum
slightli
lower
human
mice
antibcel
antitcel
respons
report
caus
sever
pneumonia
human
recent
identifi
middl
east
respiratori
syndrom
coronaviru
merscov
high
mortal
rate
reach
mice
small
laboratori
anim
suscept
merscov
infect
identif
dipeptidyl
peptidas
function
entri
receptor
merscov
open
way
develop
small
humantransgen
anim
model
adenovir
express
human
dipeptidyl
peptidas
mice
render
mice
suscept
infect
specif
tcell
respons
induc
mice
antimerscov
antibodi
abl
protect
mice
subsequ
challeng
importantli
studi
demonstr
adenoviru
deliveri
human
host
factor
repres
relev
approach
rapidli
gener
suitabl
platform
evalu
antivir
therapi
vaccin
emerg
lifethreaten
pathogen
applic
studi
bacteri
pathogenshuman
mous
model
also
util
vivo
studi
humantrop
bacteri
pathogen
listeria
monocytogen
pyogen
pathogen
neisseria
l
monocytogen
gramposit
foodborn
pathogen
caus
listeriosi
bacteria
cross
intestin
barrier
enter
blood
stream
spread
organ
host
select
mediat
bacteri
protein
internalin
b
inla
inlb
interact
human
murin
ecadherin
oral
infect
transgen
mice
express
either
human
ecadherin
human
murin
ecadherin
develop
listeriosi
show
similar
patholog
human
high
rate
mortal
transgen
mous
model
express
import
studi
pyogen
pathogen
neisseria
n
gonorrhoea
n
meningitidi
interact
protein
pyogen
major
virul
factor
import
bacteri
infect
transgen
mice
suscept
pyogen
nontransgen
mice
transgen
anim
develop
high
level
bacteremia
often
prove
lethal
infect
transgen
mice
pilat
n
meningitidi
either
intraperiton
intranas
lead
increas
bacteremia
blood
well
cerebrospin
fluid
compar
infect
nontransgen
mice
addit
mortal
observ
transgen
mice
wherea
nontransgen
control
mice
surviv
final
mice
express
human
plasminogen
experi
increas
pathogenesi
infect
pyogen
streptokinas
thought
plasminogenactiv
properti
facilit
acceler
clearanc
host
fibrin
allow
pyogen
penetr
dissemin
host
tissu
effici
transgen
mice
nontransgen
mice
surprisingli
transgen
mice
increas
level
bacteremia
wide
array
tissu
collect
continu
develop
genet
human
mice
facilit
indepth
studi
humantrop
pathogen
host
interact
better
understand
mechan
pathogenesi
provid
relev
platform
screen
efficaci
therapeut
strategi
potenti
futur
directionsth
limit
host
rang
mani
humantrop
pathogen
make
poorli
understood
term
pathogen
mechan
genet
method
describ
lend
systemat
identif
posit
neg
regul
govern
given
pathogen
host
rang
addit
number
parasit
bacteri
viral
pathogen
essenti
humanspecif
host
factor
alreadi
identifi
provid
blueprint
construct
genet
human
mous
model
ebov
marburg
viru
member
famili
filovirida
ebov
high
mortal
rate
howev
directact
treatment
vaccin
yet
avail
narrow
host
rang
ebov
restrict
human
nhp
limit
understand
ebov
pathogenesi
describ
lethal
ebov
infect
mice
requir
use
mouseadapt
ebov
strain
suggest
primatespecif
determin
regul
ebov
infect
vivo
overexpress
recent
identifi
receptor
filoviru
entri
caus
origin
nonpermiss
cell
becom
suscept
ebov
infect
indic
bona
fide
entri
factor
essenti
ebov
uptak
thu
develop
anim
model
inherit
suscept
nonadapt
strain
human
transgen
mous
could
offer
opportun
better
deciph
ebov
host
determin
infect
pathogenesi
hbv
small
dna
viru
million
chronic
carrier
worldwid
hbv
narrow
organism
cellular
host
rang
robustli
infect
human
chimpanze
hepatocyt
current
human
liver
chimer
mice
ie
xenorecipi
harbor
human
hepatocyt
model
capabl
recapitul
entir
hbv
life
cycl
howev
technic
aspect
creat
mice
tremend
thu
immunocompet
mice
inherit
suscept
hbv
would
valuabl
tool
recent
human
sodium
taurochol
cotransport
polypeptid
hntcp
identifi
receptor
hbv
entri
find
rais
possibl
develop
mous
model
inherit
suscept
hbv
peptid
essenti
hbv
entri
bind
hepatocyt
mice
rat
dog
anim
natur
suscept
hbv
infect
indic
possibl
block
follow
viru
attach
speci
restrict
might
occur
hbv
replic
coval
close
circular
dna
cccdna
templat
viral
transcript
import
establish
viral
persistencei
observ
transgen
mice
express
hbv
genom
one
previou
studi
suggest
absenc
hepatocyt
nuclear
factor
cccdna
may
form
low
level
hbv
transgen
mice
peculiar
observ
requir
independ
valid
thu
identif
addit
human
coreceptor
andor
domin
neg
murin
factor
restrict
hbv
uptak
like
necessari
order
creat
mous
model
inherit
suscept
pneumonia
oblig
human
pathogen
caus
sever
type
infect
discuss
section
impact
innat
immun
host
tropism
pneumonia
protein
cbpa
import
infect
play
role
determin
host
specif
current
mous
model
readili
suscept
pneumonia
infect
knowledg
cbpa
interact
human
pigr
secretori
compon
siga
fh
provid
tantal
possibl
develop
human
transgen
mice
suscept
pneumonia
infect
develop
model
would
provid
insight
mechan
pneumonia
infect
host
respons
plasmodium
falciparum
apoplexian
protozoan
parasit
larg
respons
caus
malaria
human
surrog
model
malaria
exist
take
advantag
plasmodi
speci
readili
infect
rodent
howev
rodent
human
parasit
strain
substanti
differ
genet
p
falciparum
gene
ortholog
plasmodium
chaubaudi
plasmodium
yoellii
plasmodium
berghei
differ
limit
predict
valu
preclin
drug
efficaci
assess
commonli
use
rodent
model
p
falciparum
complex
life
cycl
oblig
stage
mosquito
primat
includ
human
great
ape
speci
transmit
bite
infect
mosquito
parasit
first
establish
infect
human
liver
parasit
matur
transit
blood
stage
taken
blood
meal
mosquito
host
factor
govern
tissu
host
tropism
p
falciparum
remain
incomplet
defin
factor
seem
import
complet
parasit
life
cycl
basigin
bsg
appear
affectat
least
partspeciesspecif
uptak
hepatocyt
erythrocyt
respect
remain
test
whether
express
human
bsg
mice
promot
parasit
invas
given
complex
parasit
life
cycl
addit
yettobedefin
factor
like
need
overcom
speci
barrier
review
discuss
genet
engin
mice
substanti
aid
studi
humantrop
pathogen
tractabl
small
anim
model
also
repres
promis
platform
preclin
test
novel
therapeut
strategi
inde
sever
report
alreadi
pave
way
toward
use
model
evalu
prophylat
therapeut
strategi
exampl
adenosin
analog
shown
inhibit
denv
infect
within
mice
moreov
adenovirusassoci
viru
deliveri
antihcv
neutral
antibodi
mice
express
four
hcv
human
entri
factor
prevent
hcv
entri
mous
liver
howev
caveat
must
consid
creat
novel
model
refin
exist
model
mice
human
diverg
approxim
million
year
ago
although
physiolog
metabol
process
among
mammalian
speci
harbor
import
degre
conserv
worth
note
rel
strong
evolutionari
diverg
mice
human
repres
limit
recapitul
human
diseas
mous
model
inde
mous
encod
consortium
recent
aim
shed
light
mous
transcript
cellular
regulatori
mechan
consortium
abl
confirm
exist
strong
conserv
biolog
function
gene
regulatori
network
chromatin
state
mice
human
howev
also
demonstr
two
speci
exhibit
import
differ
differenti
gene
express
despit
rel
conserv
gene
sequenc
b
import
diverg
cisregulatori
landscap
mous
transcript
factor
occup
site
human
ortholog
c
exist
speciesspecif
regulatori
sequenc
enrich
repetit
dna
element
sequenc
cumul
observ
highlight
import
evolutionari
diverg
term
differenti
gene
express
transcript
regul
mice
human
futur
improv
understand
humantrop
pathogen
may
reli
develop
new
human
transgen
anim
model
base
anim
speci
display
less
evolutionari
diverg
mice
inde
proofofconcept
genet
engin
sever
speci
alreadi
made
instanc
sever
rat
model
engin
studi
human
diseas
alzheim
pig
abl
express
ectop
human
protein
prevent
bacteri
infect
recent
applic
rnamedi
genetarget
strategi
macaqu
allow
develop
genet
modifi
cynomolgu
monkey
symbol
one
achiev
altern
human
tissu
transplant
provid
unpreced
opportun
studi
human
infecti
diseas
improv
protocol
xenorecipi
strain
allow
robust
engraft
human
hepatocyt
compon
human
immun
system
follow
inject
human
hepatocyt
hematopoiet
stem
cell
respect
result
human
liver
chimer
mice
excel
model
studi
human
hepatotrop
pathogen
hepat
virus
p
falciparum
vivo
mice
longstand
histori
primarili
challeng
model
human
lymphotrop
pathogen
improv
util
human
xenotransplant
model
allow
co
engraft
tissu
engraft
procedur
recipi
need
refin
importantli
recent
demonstr
human
hepatocyt
hematopoiet
stem
cell
coengraft
singl
murin
recipi
facilit
analysi
pathogenspecif
immun
respons
immunopathogenesi
howev
current
abil
gener
relev
mous
model
harbor
still
limit
inde
absenc
low
reconstitut
human
nk
natur
killer
cell
myeloid
cell
absenc
human
hla
human
leukocyt
antigen
restrict
like
hamper
humanspecif
immun
respons
within
mous
model
thu
consider
challeng
reli
improv
reconstitut
function
within
mice
futur
gener
mice
harbor
delet
restrict
murin
immun
cell
develop
allow
express
humanspecif
hla
molecul
constitut
transient
express
humanspecif
cytokin
could
pave
way
toward
suitabl
model
studi
immun
respons
humantrop
pathogen
well
develop
antibodymedi
vaccin
recent
shown
hcv
altern
although
yet
demonstr
mice
repres
promis
platform
assess
induct
protect
immun
broad
rang
vaccin
candid
challeng
pathogen
solubl
protein
harbor
strong
antigen
properti
liveattenu
pathogen
next
decad
develop
genet
human
anim
model
combin
use
power
genet
approach
alter
genom
may
shed
light
molecular
mechan
govern
pathogen
humantrop
pathogen
potenti
uncov
novel
therapeut
vaccin
strategi
tackl
challeng
infecti
diseas
compris
dna
bind
domain
attach
foki
nucleas
domain
fnd
zfn
recogn
dna
sequenc
zfn
gener
zfn
subunit
recogn
dna
sequenc
upon
bind
target
site
fnd
dimer
result
complex
gener
dsb
talen
compos
tale
dna
bind
domain
fnd
tale
domain
made
tandem
array
amino
acid
repeat
specif
recogn
singl
dna
base
pair
nucleotid
specif
tale
domain
repeat
determin
two
amino
acid
name
repeat
variabl
diresidu
rvd
combin
rvd
almost
dna
sequenc
target
upon
bind
dna
fnd
creat
dsb
facilit
gene
knockout
knockin
complex
consist
guid
rna
grna
whose
sequenc
complementari
genet
locu
target
grna
facilit
complex
bind
target
gene
result
nucleas
protein
form
dsb
perform
nucleas
activ
monom
one
complex
need
dsb
creation
wherea
talen
zfn
requir
two
construct
exert
nucleas
activ
douam
divers
pathogen
host
tropism
virus
bacteria
parasit
vari
respect
host
rang
abl
infect
human
red
other
infect
wide
rang
vertebr
invertebr
purpl
color
red
purpl
repres
particular
level
host
rang
divers
text
includ
color
rectangl
indic
anim
group
includ
host
rang
level
identif
applic
regul
humantrop
pathogen
graphic
summari
differ
method
use
discov
host
orang
viral
blue
determin
regul
pathogen
host
tropism
shown
case
search
host
factor
guid
preliminari
experi
use
interspeci
heterokaryon
absenc
initi
guid
experi
wholegenom
screen
method
appli
identif
pathogen
factor
determin
via
screen
pathogen
determin
eg
viral
protein
amino
acid
genom
engin
pathogen
engin
pathogen
serial
passag
nonpermiss
host
detect
mutat
increas
pathogen
fit
pathogen
adapt
uncov
host
factor
may
also
allow
gener
genet
modifi
pathogen
abl
overcom
potenti
host
restrict
factor
dot
line
collect
identif
host
factor
regul
tropism
human
pathogen
combin
develop
sever
genet
tool
allow
gener
genet
human
mice
suitabl
anim
model
permiss
humantrop
pathogen
anim
model
repres
promis
platform
studi
humantrop
pathogen
vivo
well
develop
vaccin
therapeut
strategi
challeng
pathogen
abbrevi
hbv
hepat
b
viru
hcv
hepat
c
viru
